These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 35440542)

  • 1. A proteogenomic analysis of clear cell renal cell carcinoma in a Chinese population.
    Qu Y; Feng J; Wu X; Bai L; Xu W; Zhu L; Liu Y; Xu F; Zhang X; Yang G; Lv J; Chen X; Shi GH; Wang HK; Cao DL; Xiang H; Li L; Tan S; Gan HL; Sun MH; Qiu J; Zhang H; Zhao JY; Ye D; Ding C
    Nat Commun; 2022 Apr; 13(1):2052. PubMed ID: 35440542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive proteogenomic characterization of rare kidney tumors.
    Li GX; Chen L; Hsiao Y; Mannan R; Zhang Y; Luo J; Petralia F; Cho H; Hosseini N; Leprevost FDV; Calinawan A; Li Y; Anand S; Dagar A; Geffen Y; Kumar-Sinha C; Chugh S; Le A; Ponce S; Guo S; Zhang C; Schnaubelt M; Al Deen NN; Chen F; Caravan W; Houston A; Hopkins A; Newton CJ; Wang X; Polasky DA; Haynes S; Yu F; Jing X; Chen S; Robles AI; Mesri M; Thiagarajan M; An E; Getz GA; Linehan WM; Hostetter G; Jewell SD; Chan DW; Wang P; Omenn GS; Mehra R; Ricketts CJ; Ding L; Chinnaiyan AM; Cieslik MP; Dhanasekaran SM; Zhang H; Nesvizhskii AI;
    Cell Rep Med; 2024 May; 5(5):101547. PubMed ID: 38703764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness.
    Li Y; Lih TM; Dhanasekaran SM; Mannan R; Chen L; Cieslik M; Wu Y; Lu RJ; Clark DJ; Kołodziejczak I; Hong R; Chen S; Zhao Y; Chugh S; Caravan W; Naser Al Deen N; Hosseini N; Newton CJ; Krug K; Xu Y; Cho KC; Hu Y; Zhang Y; Kumar-Sinha C; Ma W; Calinawan A; Wyczalkowski MA; Wendl MC; Wang Y; Guo S; Zhang C; Le A; Dagar A; Hopkins A; Cho H; Leprevost FDV; Jing X; Teo GC; Liu W; Reimers MA; Pachynski R; Lazar AJ; Chinnaiyan AM; Van Tine BA; Zhang B; Rodland KD; Getz G; Mani DR; Wang P; Chen F; Hostetter G; Thiagarajan M; Linehan WM; Fenyö D; Jewell SD; Omenn GS; Mehra R; Wiznerowicz M; Robles AI; Mesri M; Hiltke T; An E; Rodriguez H; Chan DW; Ricketts CJ; Nesvizhskii AI; Zhang H; Ding L;
    Cancer Cell; 2023 Jan; 41(1):139-163.e17. PubMed ID: 36563681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma.
    Clark DJ; Dhanasekaran SM; Petralia F; Pan J; Song X; Hu Y; da Veiga Leprevost F; Reva B; Lih TM; Chang HY; Ma W; Huang C; Ricketts CJ; Chen L; Krek A; Li Y; Rykunov D; Li QK; Chen LS; Ozbek U; Vasaikar S; Wu Y; Yoo S; Chowdhury S; Wyczalkowski MA; Ji J; Schnaubelt M; Kong A; Sethuraman S; Avtonomov DM; Ao M; Colaprico A; Cao S; Cho KC; Kalayci S; Ma S; Liu W; Ruggles K; Calinawan A; Gümüş ZH; Geiszler D; Kawaler E; Teo GC; Wen B; Zhang Y; Keegan S; Li K; Chen F; Edwards N; Pierorazio PM; Chen XS; Pavlovich CP; Hakimi AA; Brominski G; Hsieh JJ; Antczak A; Omelchenko T; Lubinski J; Wiznerowicz M; Linehan WM; Kinsinger CR; Thiagarajan M; Boja ES; Mesri M; Hiltke T; Robles AI; Rodriguez H; Qian J; Fenyö D; Zhang B; Ding L; Schadt E; Chinnaiyan AM; Zhang Z; Omenn GS; Cieslik M; Chan DW; Nesvizhskii AI; Wang P; Zhang H;
    Cell; 2019 Oct; 179(4):964-983.e31. PubMed ID: 31675502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotinamide-N-methyltransferase is a promising metabolic drug target for primary and metastatic clear cell renal cell carcinoma.
    Reustle A; Menig LS; Leuthold P; Hofmann U; Stühler V; Schmees C; Becker M; Haag M; Klumpp V; Winter S; Büttner FA; Rausch S; Hennenlotter J; Fend F; Scharpf M; Stenzl A; Bedke J; Schwab M; Schaeffeler E
    Clin Transl Med; 2022 Jun; 12(6):e883. PubMed ID: 35678045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotinamide N-methyltransferase induces cellular invasion through activating matrix metalloproteinase-2 expression in clear cell renal cell carcinoma cells.
    Tang SW; Yang TC; Lin WC; Chang WH; Wang CC; Lai MK; Lin JY
    Carcinogenesis; 2011 Feb; 32(2):138-45. PubMed ID: 21045016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteogenomics of clear cell renal cell carcinoma response to tyrosine kinase inhibitor.
    Zhang H; Bai L; Wu XQ; Tian X; Feng J; Wu X; Shi GH; Pei X; Lyu J; Yang G; Liu Y; Xu W; Anwaier A; Zhu Y; Cao DL; Xu F; Wang Y; Gan HL; Sun MH; Zhao JY; Qu Y; Ye D; Ding C
    Nat Commun; 2023 Jul; 14(1):4274. PubMed ID: 37460463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteogenomic, Epigenetic, and Clinical Implications of Recurrent Aberrant Splice Variants in Clear Cell Renal Cell Carcinoma.
    Chang A; Chakiryan NH; Du D; Stewart PA; Zhang Y; Tian Y; Soupir AC; Bowers K; Fang B; Morganti A; Teer JK; Kim Y; Spiess PE; Chahoud J; Noble JD; Putney RM; Berglund AE; Robinson TJ; Koomen JM; Wang L; Manley BJ
    Eur Urol; 2022 Oct; 82(4):354-362. PubMed ID: 35718636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Ligand-Receptor Pairs Associated With Tumour Characteristics in Clear Cell Renal Cell Carcinoma.
    Liu F; Wang P; Sun W; Jiang Y; Gong Q
    Front Immunol; 2022; 13():874056. PubMed ID: 35734169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of transforming growth factor beta 1 in the transcriptional regulation of nicotinamide N-methyltransferase in clear cell renal cell carcinoma.
    Campagna R; Cecati M; Pozzi V; Fumarola S; Pompei V; Milanese G; Galosi AB; Sartini D; Emanuelli M
    Cell Mol Biol (Noisy-le-grand); 2018 May; 64(7):51-55. PubMed ID: 29974846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GRP78 expression in tumor and perinephric adipose tissue is not an optimal risk stratification marker for clear cell renal cell carcinoma.
    Shen K; Vesey DA; Ellis RJ; Del Vecchio SJ; Cho Y; Teixeira-Pinto A; McGuckin MA; Johnson DW; Gobe GC
    PLoS One; 2019; 14(1):e0210246. PubMed ID: 30653515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
    Rabjerg M
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GPX8 regulates clear cell renal cell carcinoma tumorigenesis through promoting lipogenesis by NNMT.
    Nguyen TTM; Nguyen TH; Kim HS; Dao TTP; Moon Y; Seo M; Kang S; Mai VH; An YJ; Jung CR; Kim JM; Park S
    J Exp Clin Cancer Res; 2023 Feb; 42(1):42. PubMed ID: 36750850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Large-scale transcriptome profiles reveal robust 20-signatures metabolic prediction models and novel role of G6PC in clear cell renal cell carcinoma.
    Xu WH; Xu Y; Tian X; Anwaier A; Liu WR; Wang J; Zhu WK; Cao DL; Wang HK; Shi GH; Qu YY; Zhang HL; Ye DW
    J Cell Mol Med; 2020 Aug; 24(16):9012-9027. PubMed ID: 32567187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of a Novel Immune-Related lncRNA Pair Signature with Prognostic Significance for Kidney Clear Cell Renal Cell Carcinoma.
    Sun JX; Xia QD; Liu CQ; Xu JZ; Xun Y; Lu JL; Hu J; Wang SG
    Dis Markers; 2021; 2021():8800358. PubMed ID: 34512816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bromodomain-containing protein 9 is a prognostic biomarker associated with immune infiltrates and promotes tumor malignancy through activating notch signaling pathway in negative HIF-2α clear cell renal cell carcinoma.
    Lou W; Gao K; Xu C; Li Q
    IUBMB Life; 2021 Nov; 73(11):1334-1347. PubMed ID: 34415102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor biology of non-metastatic stages of clear cell renal cell carcinoma; overexpression of stearoyl desaturase-1, EPO/EPO-R system and hypoxia-related proteins.
    Stoyanoff TR; Rodríguez JP; Todaro JS; Espada JD; Colavita JP; Brandan NC; Torres AM; Aguirre MV
    Tumour Biol; 2016 Oct; 37(10):13581-13593. PubMed ID: 27468719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-Omics Analysis of the Prognosis and Biological Function for TRPV Channel Family in Clear Cell Renal Cell Carcinoma.
    Jiang Y; Han D; Zhao Y; Zhang C; Shi X; Gu W
    Front Immunol; 2022; 13():872170. PubMed ID: 35558077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteogenomic characterization of MiT family translocation renal cell carcinoma.
    Qu Y; Wu X; Anwaier A; Feng J; Xu W; Pei X; Zhu Y; Liu Y; Bai L; Yang G; Tian X; Su J; Shi GH; Cao DL; Xu F; Wang Y; Gan HL; Ni S; Sun MH; Zhao JY; Zhang H; Ye D; Ding C
    Nat Commun; 2022 Dec; 13(1):7494. PubMed ID: 36470859
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Lin W; Chen X; Chen T; Liu J; Ye Y; Chen L; Qiu X; Chia-Hsien Cheng J; Zhang L; Wu J; Qiu S
    DNA Cell Biol; 2020 Jun; 39(6):1000-1011. PubMed ID: 32282241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.